The targets and indicators of Russia’s state public health program up to 2020
Studying the targets and indicators of the Public Health Development Program up to 2020 concerning antituberculosis (anti-TB) care to the population may lead to the conclusion that they may be fulfilled in the Russian Federation as a whole. The difficulties in fulfilling the indicators are associate...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEW TERRA Publishing House
2014-12-01
|
Series: | Tuberkulez i Bolezni Lëgkih |
Subjects: | |
Online Access: | https://www.tibl-journal.com/jour/article/view/312 |
id |
doaj-c18b9de3a8fe45e59077dc8694d1d29f |
---|---|
record_format |
Article |
spelling |
doaj-c18b9de3a8fe45e59077dc8694d1d29f2021-07-28T20:57:40ZrusNEW TERRA Publishing HouseTuberkulez i Bolezni Lëgkih2075-12302542-15062014-12-010122534312The targets and indicators of Russia’s state public health program up to 2020O. B. Nechaeva0S. A. Sterlikov1N. B. Khurieva2ФГБУ «Центральный НИИ организации и информатизации здравоохранения» Минздрава России, г. МоскваФГБУ «Центральный НИИ организации и информатизации здравоохранения» Минздрава России, г. МоскваФГБУ «Центральный НИИ организации и информатизации здравоохранения» Минздрава России, г. МоскваStudying the targets and indicators of the Public Health Development Program up to 2020 concerning antituberculosis (anti-TB) care to the population may lead to the conclusion that they may be fulfilled in the Russian Federation as a whole. The difficulties in fulfilling the indicators are associated with the low level of tuberculosis detection in a number of subjects of the Russian Federation; the continuing development of the HIV epidemic; the inadequate development of bacteriological diagnosis of the drug sensitivity of the tuberculosis pathogen to anti-TB drugs; the nonuniform funding of anti-TB measures in the subjects of the Russian Federation – the annual financing per tuberculosis patient differs by 40 times, including that of the purchase of anti-TB drugs by 63 times. Having no federal financial assistance in purchasing reserve anti-TB drugs and consumables for microbiological tests, it is impossible to diagnose multidrug resistance and to cure patients with multidrug-resistant tuberculosis at the expense of the budgets of the Russian Federation’s subjects.https://www.tibl-journal.com/jour/article/view/312tuberculosistuberculosis institutionspublic health financingmultidrug resistancehiv infectionrussia’s state public health development programtargetsindicators |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
O. B. Nechaeva S. A. Sterlikov N. B. Khurieva |
spellingShingle |
O. B. Nechaeva S. A. Sterlikov N. B. Khurieva The targets and indicators of Russia’s state public health program up to 2020 Tuberkulez i Bolezni Lëgkih tuberculosis tuberculosis institutions public health financing multidrug resistance hiv infection russia’s state public health development program targets indicators |
author_facet |
O. B. Nechaeva S. A. Sterlikov N. B. Khurieva |
author_sort |
O. B. Nechaeva |
title |
The targets and indicators of Russia’s state public health program up to 2020 |
title_short |
The targets and indicators of Russia’s state public health program up to 2020 |
title_full |
The targets and indicators of Russia’s state public health program up to 2020 |
title_fullStr |
The targets and indicators of Russia’s state public health program up to 2020 |
title_full_unstemmed |
The targets and indicators of Russia’s state public health program up to 2020 |
title_sort |
targets and indicators of russia’s state public health program up to 2020 |
publisher |
NEW TERRA Publishing House |
series |
Tuberkulez i Bolezni Lëgkih |
issn |
2075-1230 2542-1506 |
publishDate |
2014-12-01 |
description |
Studying the targets and indicators of the Public Health Development Program up to 2020 concerning antituberculosis (anti-TB) care to the population may lead to the conclusion that they may be fulfilled in the Russian Federation as a whole. The difficulties in fulfilling the indicators are associated with the low level of tuberculosis detection in a number of subjects of the Russian Federation; the continuing development of the HIV epidemic; the inadequate development of bacteriological diagnosis of the drug sensitivity of the tuberculosis pathogen to anti-TB drugs; the nonuniform funding of anti-TB measures in the subjects of the Russian Federation – the annual financing per tuberculosis patient differs by 40 times, including that of the purchase of anti-TB drugs by 63 times. Having no federal financial assistance in purchasing reserve anti-TB drugs and consumables for microbiological tests, it is impossible to diagnose multidrug resistance and to cure patients with multidrug-resistant tuberculosis at the expense of the budgets of the Russian Federation’s subjects. |
topic |
tuberculosis tuberculosis institutions public health financing multidrug resistance hiv infection russia’s state public health development program targets indicators |
url |
https://www.tibl-journal.com/jour/article/view/312 |
work_keys_str_mv |
AT obnechaeva thetargetsandindicatorsofrussiasstatepublichealthprogramupto2020 AT sasterlikov thetargetsandindicatorsofrussiasstatepublichealthprogramupto2020 AT nbkhurieva thetargetsandindicatorsofrussiasstatepublichealthprogramupto2020 AT obnechaeva targetsandindicatorsofrussiasstatepublichealthprogramupto2020 AT sasterlikov targetsandindicatorsofrussiasstatepublichealthprogramupto2020 AT nbkhurieva targetsandindicatorsofrussiasstatepublichealthprogramupto2020 |
_version_ |
1721264315890139136 |